Patent ID: 8329639

Claim:
A liposomal vaccine formulation comprising: (a) a glycolipopeptide of structure: SEQ ID NO: 2 H 2 N-TSAPDT(Tn)RPAPGS(Tn)T(Tn)APPAHGVTSAPDT(Tn)R PAPGS(Tn)T(Tn)APPAHGVS*S*L-OH wherein Tn represents, independently at each occurrence, α-N-Acetylgalactosamine (GalNAcα1) covalently attached to a Serine or Threonine residue; and *represents, independently at each occurrence, a C14 lipid covalently attached to a Serine residue; (b) an adjuvant of structure: or a pharmaceutically acceptable salt thereof; and (c) a carrier lipid.